Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies
Atara Biotherapeutics
Atara Biotherapeutics
AbbVie
University of California, San Francisco
ADC Therapeutics S.A.
Seagen Inc.
Molecular Templates, Inc.
Barbara Ann Karmanos Cancer Institute
Arbeitsgemeinschaft medikamentoese Tumortherapie